Skip to content

A comparative clinical study to find out the effect of Nishamlaki choorna in Madhumeha(sugar) patients with and without walking exercise.

A comparative clinical study 0f Nishamlaki choorna on Madhumeha with special reference to Diabetes Mellitus(DM-II) with and without Chankramana - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108596
Enrollment
60
Registered
2026-04-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Govt Ayurvedic College Patna
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a.Patient willing for the research trial and give their consent to participate in the study b.Patients suffering from sign and symptoms based on both ayurvedic and modern context -Impaired fasting glucose (Exceed normal fasting level) & Impaired PPBS. c.Patients between age group of 20 to 60 years are included in research without any bar of caste, sex, and religion after taking consent from patient.

Exclusion criteria

Exclusion criteria: a.Patient whose age is less than 20 years and more than 60 years. b.Patients are not willing for trial and support. c.FBS level more than 200mg/dl. d.Patients having complications of diabetes mellitus and severe disease like AIDS, Cancer, T.B, Severe Heart disease, Liver disease, Renal failure, anxiety disorder etc.

Design outcomes

Primary

MeasureTime frame
Null Hypothesis [Ho] There is no significant difference in the clinical outcomes of Nishamlaki Choorna in patients of Madhumeha (DM type 2) with and without Chankramana. Alternate Hypothesis [H1] There is a significant difference in the clinical outcomes of Nishamalaki Choorna in patients of Madhumeha (Type 2 Diabetes Mellitus) with and without Chankramana (walking). Timepoint: At 0 day(start of trial) and then after each 15 days interval up to 60 days.

Secondary

MeasureTime frame
nilTimepoint:

Countries

India

Contacts

Public ContactSunita Pandey

Government Ayurvedic College Patna

drpsunita@gmail.com9431259606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026